Therapeutic Solutions International Inc (TSOI)

[centsability4me]

CAPO SAB member Dr. Lon Schneider

http://www.keckmedicine.org/doctor/lon-s-schneider/

Lon Schneider, M.D.

Professor of psychiatry, neurology and gerontology at USC. He directs the USC State of California Alzheimer’s Disease Center and the clinical core and pharmacology program of the USC NIH/NIA Alzheimer’s Disease Research Center. He has enormous expertise in clinical trials methods, instruments and rating scales for dementia trials, meta-analyses, and drug development. He serves on the steering committees of the NIH ADCS, the NIH ADNI, and the Alzheimer Prevention Initiative. He is internationally recognized in clinical drug development for AD, neuropsychiatric, and behavioral disorders, has led numerous clinical trials for AD and MCI therapeutics, consults with numerous development programs, participated in the design and operations of several early and later phase proprietary development programs for AD, and directed multicenter trials in AD and major depression.